Vincenza Granata1, Roberta Fusco1, Antonio Avallone2, Alfonso De Stefano2, Alessandro Ottaiano2, Carolina Sbordone3, Luca Brunese3, Francesco Izzo4, Antonella Petrillo1. 1. Radiology Division, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semmola, 80121 Naples, Italy. 2. Abdominal Oncology Division, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semmola, 80121 Naples, Italy. 3. Radiology Division, Università degli Studi del Molise, Via Francesco De Sanctis, 86100 Campobasso, Italy. 4. Hepatobiliary Surgical Oncology Division, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semmola, 80121 Naples, Italy.
Abstract
Purpose: To assess the association of RAS mutation status and radiomics-derived data by Contrast Enhanced-Magnetic Resonance Imaging (CE-MRI) in liver metastases. Materials and Methods: 76 patients (36 women and 40 men; 59 years of mean age and 36-80 years as range) were included in this retrospective study. Texture metrics and parameters based on lesion morphology were calculated. Per-patient univariate and multivariate analysis were made. Wilcoxon-Mann-Whitney U test, receiver operating characteristic (ROC) analysis, pattern recognition approaches with features selection approaches were considered. Results: Significant results were obtained for texture features while morphological parameters had not significant results to classify RAS mutation. The results showed that using a univariate analysis was not possible to discriminate accurately the RAS mutation status. Instead, considering a multivariate analysis and classification approaches, a KNN exclusively with texture parameters as predictors reached the best results (AUC of 0.84 and an accuracy of 76.9% with 90.0% of sensitivity and 67.8% of specificity on training set and an accuracy of 87.5% with 91.7% of sensitivity and 83.3% of specificity on external validation cohort). Conclusions: Texture parameters derived by CE-MRI and combined using multivariate analysis and patter recognition approaches could allow stratifying the patients according to RAS mutation status.
Purpose: To assess the association of RAS mutation status and radiomics-derived data by Contrast Enhanced-Magnetic Resonance Imaging (CE-MRI) in liver metastases. Materials and Methods: 76 patients (36 women and 40 men; 59 years of mean age and 36-80 years as range) were included in this retrospective study. Texture metrics and parameters based on lesion morphology were calculated. Per-patient univariate and multivariate analysis were made. Wilcoxon-Mann-Whitney U test, receiver operating characteristic (ROC) analysis, pattern recognition approaches with features selection approaches were considered. Results: Significant results were obtained for texture features while morphological parameters had not significant results to classify RAS mutation. The results showed that using a univariate analysis was not possible to discriminate accurately the RAS mutation status. Instead, considering a multivariate analysis and classification approaches, a KNN exclusively with texture parameters as predictors reached the best results (AUC of 0.84 and an accuracy of 76.9% with 90.0% of sensitivity and 67.8% of specificity on training set and an accuracy of 87.5% with 91.7% of sensitivity and 83.3% of specificity on external validation cohort). Conclusions: Texture parameters derived by CE-MRI and combined using multivariate analysis and patter recognition approaches could allow stratifying the patients according to RAS mutation status.
Authors: Vivek Verma; Charles B Simone; Sunil Krishnan; Steven H Lin; Jinzhong Yang; Stephen M Hahn Journal: J Natl Cancer Inst Date: 2017-07-01 Impact factor: 13.506
Authors: Dirk Walter; Patrick N Harter; Florian Battke; Ria Winkelmann; Markus Schneider; Katharina Holzer; Christine Koch; Jörg Bojunga; Stefan Zeuzem; Martin Leo Hansmann; Jan Peveling-Oberhag; Oliver Waidmann Journal: Sci Rep Date: 2018-02-28 Impact factor: 4.379
Authors: Liting Shi; Yaoyao He; Zilong Yuan; Stanley Benedict; Richard Valicenti; Jianfeng Qiu; Yi Rong Journal: Technol Cancer Res Treat Date: 2018-01-01
Authors: Alex Zwanenburg; Martin Vallières; Mahmoud A Abdalah; Hugo J W L Aerts; Vincent Andrearczyk; Aditya Apte; Saeed Ashrafinia; Spyridon Bakas; Roelof J Beukinga; Ronald Boellaard; Marta Bogowicz; Luca Boldrini; Irène Buvat; Gary J R Cook; Christos Davatzikos; Adrien Depeursinge; Marie-Charlotte Desseroit; Nicola Dinapoli; Cuong Viet Dinh; Sebastian Echegaray; Issam El Naqa; Andriy Y Fedorov; Roberto Gatta; Robert J Gillies; Vicky Goh; Michael Götz; Matthias Guckenberger; Sung Min Ha; Mathieu Hatt; Fabian Isensee; Philippe Lambin; Stefan Leger; Ralph T H Leijenaar; Jacopo Lenkowicz; Fiona Lippert; Are Losnegård; Klaus H Maier-Hein; Olivier Morin; Henning Müller; Sandy Napel; Christophe Nioche; Fanny Orlhac; Sarthak Pati; Elisabeth A G Pfaehler; Arman Rahmim; Arvind U K Rao; Jonas Scherer; Muhammad Musib Siddique; Nanna M Sijtsema; Jairo Socarras Fernandez; Emiliano Spezi; Roel J H M Steenbakkers; Stephanie Tanadini-Lang; Daniela Thorwarth; Esther G C Troost; Taman Upadhaya; Vincenzo Valentini; Lisanne V van Dijk; Joost van Griethuysen; Floris H P van Velden; Philip Whybra; Christian Richter; Steffen Löck Journal: Radiology Date: 2020-03-10 Impact factor: 29.146
Authors: Roberta Fusco; Mario Sansone; Salvatore Filice; Guglielmo Carone; Daniela Maria Amato; Carlo Sansone; Antonella Petrillo Journal: J Med Biol Eng Date: 2016-08-31 Impact factor: 1.553